Search
Filter by Topic
- People (35) Apply People filter
- Reproduction (17) Apply Reproduction filter
- Technologies (13) Apply Technologies filter
- Experiments (11) Apply Experiments filter
- Publications (11) Apply Publications filter
- Theories (10) Apply Theories filter
- Legal (8) Apply Legal filter
- Processes (5) Apply Processes filter
- Disorders (4) Apply Disorders filter
- Organizations (4) Apply Organizations filter
- Ethics (2) Apply Ethics filter
- Reproductive Health Arizona (2) Apply Reproductive Health Arizona filter
- Outreach (1) Apply Outreach filter
- Religion (1) Apply Religion filter
Filter by Format
“Pregnancy Established in an Infertile Patient After Transfer of a Donated Embryo Fertilized In Vitro” (1983), by Alan Trounson, John Leeton, Mandy Besanko, Carl Wood, and Angelo Conti
In 1983, researchers Alan Trounson, John Leeton, Carl Wood, Mandy Besanko, and Angelo Conti published the article “Pregnancy Established in an Infertile Patient After Transfer of a Donated Embryo Fertilized In Vitro” in The British Medical Journal. In the article, the authors discuss one of the first successful experiments using in vitro fertilization, or IVF, with the use of a human donor embryo at the Monash University and Queen Victoria Medical Center in Melbourne, Australia.
Format: Articles
Subject: Publications, Publications, Reproduction, Processes
History of the Monash IVF Research Program from 1971 to 1989
In 1971, a group of researchers founded the Monash IVF Research Program with the mission to discover how in vitro fertilization, or IVF, techniques could become a treatment for infertility in both men and women. The program included researcher Carl Wood and colleagues John Leeton, Alex Lopata, Alan Trounson, and Ian Johnston at the Queen Victoria Medical Center and Royal Women’s Hospital in Melbourne, Australia. Since the program’s establishment in 1971, the Monash IVF Research Program has helped to develop and implement many IVF technologies still used in clinical practice as of 2020.
Format: Articles
Subject: Organizations, Reproduction
Thomson, et al. v. Thompson, et al. (2001)
Thomson, et al. v. Thompson, et al. was a lawsuit filed in the United States District Court for the District of Columbia on 8 May 2001 as Civil Action Number 01-CV-0973. This lawsuit was filed in hopes of gaining injunctive relief against a moratorium on the federal funding of stem cell research. The plaintiffs in the case were seven prominent scientists who performed embryonic stem cell research and three patients: James Thomson, Roger Pedersen, John Gearhart, Douglas Melton, Dan Kaufman, Alan Trounson, Martin Pera, Christopher Reeve, James Cordy, and James Tyree.
Format: Articles
Subject: Legal
Alan Mathison Turing (1912-1954)
Alan Mathison Turing was a British mathematician and computer scientist who lived in the early twentieth century. Among important contributions in the field of mathematics, computer science, and philosophy, he developed a mathematical model of morphogenesis. This model describing biological growth became fundamental for research on the process of embryo development.
Format: Articles
Subject: People
Stanley Alan Plotkin (1932– )
Stanley Alan Plotkin developed vaccines in the United States during the mid to late twentieth century. Plotkin began his research career at the Wistar Institute in Philadelphia, Pennsylvania, where he studied the rubella virus. In pregnant women, the rubella virus caused congenital rubella syndrome in the fetus, which led to various malformations and birth defects. Using WI-38 cells, a line of cells that originated from tissues of aborted fetuses, Plotkin successfully created RA27/3, a weakened strain of the rubella virus, which he then used to develop a rubella vaccine.
Format: Articles
Subject: People
Robert Alan Good (1922-2003)
Robert Alan Good was an American physician and scientific researcher who explored the cellular mechanisms of immunity. His research and discoveries earned him the label of "father of modern immunology." Though his work in immunology is considered his greatest scientific achievement, Good is also well known for his work with tissue engineering. From his research on immunology, Good was able to perform the first successful allogeneic (donor and recipient are unrelated) bone marrow transplant.
Format: Articles
Subject: People
"The Chemical Basis of Morphogenesis" (1952), by Alan M. Turing
In 1952 the article "The Chemical Basis of Morphogenesis" by the British mathematician and logician Alan M. Turing was published in Philosophical Transactions of the Royal Society of London. In that article Turing describes a mathematical model of the growing embryo. He uses this model to show how embryos develop patterns and structures (e.g., coat patterns and limbs, respectively). Turing's mathematical approach became fundamental for explaining the developmental process of embryos.
Format: Articles
Subject: Publications
Stanley Alan Plotkin's Development of a Rubella Vaccine (1969)
In the US during the late 1960s, Stanley Alan Plotkin, John D. Farquhar, Michael Katz, and Fritz Buser isolated a strain of the infectious disease rubella and developed a rubella vaccine with a weakened, or attenuated, version of the virus strain. Rubella, also called German measles, is a highly contagious disease caused by the rubella virus that generally causes mild rashes and fever. However, in pregnant women, rubella infections can lead to developmental defects in their fetuses.
Format: Articles
Subject: Experiments
“Revival of Spermatozoa after Dehydration and Vitrification at Low Temperatures” (1949), by Christopher Polge, Audrey Ursula Smith, and Alan Sterling Parkes
In the 1949 article “Revival of Spermatozoa after Dehydration and Vitrification at Low Temperatures,” researchers Christopher Polge, Audrey Ursula Smith, and Alan Sterling Parkes demonstrated that glycerol prevents cells from dying while being frozen. Polge and his colleagues discussed several procedures in which they had treated sperm cells from various species with glycerol, froze those cells, and then observed the physiological effects that freezing had on the treated sperm. The researchers concluded that glycerol safely preserves sperm samples from a variety of species.
Format: Articles
Subject: Publications
Edwin Carlyle (Carl) Wood (1929–2011)
Edwin Carlyle Wood, also known as Carl Wood, was a physician who helped develop in vitro fertilization, or IVF, treatments. From 1964 to 1992, Wood worked as a professor of obstetrics and gynecology at Monash University in Melbourne, Australia, where he was one of the first in the world to lead a team of physicians to establish IVF as a proven treatment for infertility. IVF refers to a medical procedure in which scientists inseminate an egg cell with a sperm cell outside of the body, such as in a glass dish in a clinical setting.
Format: Articles
Subject: People, Technologies, Reproduction
“Transfer of a Human Zygote” (1973), by David De Kretzer, Peter Dennis, Bryan Hudson, John Leeton, Alexander Lopata, Ken Outch, James Talbot, and Carl Wood
On 29 September 1973, researchers David De Kretzer, Peter Dennis, Bryan Hudson, John Leeton, Alexander Lopata, Ken Outch, James Talbot, and Carl Wood published “Transfer of a Human Zygote,” in The Lancet. In the article, the authors describe an experiment that resulted in one of the first pregnancies established via in vitro fertilization, or IVF. Prior to the article’s publication in 1973, there was no published evidence demonstrating whether IVF treatment would work in humans, although evidence existed showing that IVF worked in other mammals for breeding purposes.
Format: Articles
Subject: Publications, Processes
Bicoid
Bicoid is the protein product of a maternal-effect gene unique to flies of the genus Drosophila . In 1988 Christiane Nüsslein-Volhard identified bicoid as the first known morphogen . A morphogen is a molecule that determines the fate and phenotype of a group of cells through a concentration gradient across that developing region. The bicoid gradient, which extends across the anterior-posterior axis of Drosophila embryos, organizes the head and thorax.
Format: Articles
Subject: Processes
Ernest John Christopher Polge (1926-2006)
Twentieth-century researcher Ernest John Christopher Polge studied the reproductive processes of livestock and determined a method to successfully freeze, thaw, and utilize viable sperm cells to produce offspring in animals. In 1949, Polge identified glycerol as a cryoprotectant, or a medium that enables cells to freeze without damaging their cellular components or functions. Several years later, Polge used glycerol in a freezing process called vitrification, which enabled him to freeze poultry sperm, thaw that sperm, and use it to fertilize vertebrate embryos.
Format: Articles
Subject: People
In Vitro Fertilization
In vitro fertilization (IVF) is an assisted reproductive technology (ART) initially introduced by Patrick Steptoe and Robert Edwards in the 1970s to treat female infertility caused by damaged or blocked fallopian tubes. This major breakthrough in embryo research has provided large numbers of women the possibility of becoming pregnant, and subsequent advances have dramatically increased their chances. IVF is a laboratory procedure in which sperm and egg are fertilized outside the body; the term "in vitro" is Latin for "in glass."
Format: Articles
Subject: Technologies, Reproduction
Keith Henry Stockman Campbell (1954-2012)
Keith Henry Stockman Campbell studied embryo growth and cell differentiation during the twentieth and twenty-first centuries in the UK. In 1995, Campbell and his scientific team used cells grown and differentiated in a laboratory to clone sheep for the first time. They named these two sheep Megan and Morag. Campbell and his team also cloned a sheep from adult cells in 1996, which they named Dolly. Dolly was the first mammal cloned from specialized adult (somatic) cells with the technique of somatic cell nuclear transfer (SCNT).
Format: Articles
Subject: People
Christopher Polge and Lionel Edward Aston Rowson’s Experiments on the Freezing of Bull Spermatozoa (1950–1952)
In 1952, researchers Christopher Polge and Lionel Edward Aston Rowson, who worked at the Animal Research Center in Cambridge, England, detailed several experiments on protocols for freezing bull semen for use in the artificial insemination of cows. Freezing sperm extends the life of a viable sperm sample and allows it to be used at later times, such as in artificial insemination. The researchers examined the effects of freezing conditions on bull sperm and how well they produce fertilized embryos once thawed.
Format: Articles
Subject: Experiments
"Human Factor IX Transgenic Sheep Produced by Transfer of Nuclei from Transfected Fetal Fibroblasts" (1997), by Angelika E. Schnieke, et al.
In the 1990s, researchers working at the Roslin Institute in Edinburgh, Scotland, performed cloning experiments in collaboration with PPL Therapeutics in Roslin, Scotland, on human coagulation factor IX, a protein. The team of scientists used the methods identified during the Dolly experiments to produce transgenic livestock capable of producing milk containing human blood clotting factor IX, which helps to treat a type of hemophilia.
Format: Articles
Subject: Experiments
Freedom of Access to Clinic Entrances Act (1994)
On 26 May 1994, US President Bill Clinton signed the Freedom of Access to Clinic Entrances Act in to law, which federally criminalized acts of obstruction and violence towards reproductive health clinics. The law was a reaction to the increasing violence toward abortion clinics, providers, and patients during the 1990s. That violence included clinic blockades and protests, assaults on physicians and patients, and murders. The Freedom of Access to Clinic Entrances Act established
Format: Articles
Subject: Legal
"Screening for Congenital Hypothyroidism" (1991), by Delbert A. Fisher
In his 1991 article Screening for Congenital Hypothyroidism, Delbert A. Fisher in the US reported on the implementation and impact of mass neonatal screening programs for congenital hypothyroidism (CH) from the early 1970s through 1991. CH is a condition that causes stunted mental and physical development in newborns unless treatment begins within the first three months of the newborn's life. In the early 1970s, regions in Canada and the US had implemented screening programs to diagnose and treat CH as quickly as possible after the infant's birth.
Format: Articles
Subject: Publications, Technologies
The Source-Sink Model
The source-sink model, first proposed by biologist Francis Crick in 1970, is a theoretical system for how morphogens distribute themselves across small fields of early embryonic cells. A morphogen is a substance that determines the fate and phenotype of a group of cells through a concentration gradient of itself across that group. Crick’s theory has been experimentally confirmed with several morphogens, most notably with the protein bicoid , the first discovered morphogen. The model provides a theoretical structure for the understanding of some features of early embryonic development.
Format: Articles
Subject: Theories
De Monstruorum Causis, Natura et Differentiis (On the Reasons, Nature and Differences of Monsters) (1616), by Fortunio Liceti
In 1616 in Padua, Italy, Fortunio Liceti, a professor of natural philosophy and medicine, wrote and published the first edition of De Monstruorum Causis, Natura et Differentiis (On the Reasons, Nature, and Differences of Monsters), hereafter De monstruorum. In De monstruorum, Liceti chronologically documented cases of human and animal monsters from antiquity to the seventeenth century. During the seventeenth century, many people considered such monsters as frightening signs of evil cursed by spiritual or supernatural entities.
Format: Articles
Subject: Theories
Preimplantation Genetic Diagnosis
Preimplantation genetic diagnosis (PGD) involves testing for specific genetic conditions prior to the implantation of an embryo in the uterine wall. This form of genetic screening has been made possible by the growth of in-vitro fertilization (IVF) technology, which allows for the early stages of development to occur in a laboratory dish rather than in vivo. The purpose of PGD is to identify what are considered to be abnormal embryos in order to select the most desirable embryos for implantation.
Format: Articles
Subject: Technologies, Reproduction
Assisted Human Reproduction Canada (AHRC)
Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use of such research and technology while enforcing the guidelines and restrictions laid out by the AHR Act.
Format: Articles
Subject: Organizations, Reproduction
Clomiphene Citrate
Clomiphene citrate, more commonly known by its brand names Clomid and Serophene, is a medication prescribed to women to stimulate ovulation in order to treat infertility. It stimulates ovulation in women who do not ovulate or ovulate irregularly. This drug was created by Dr. Frank Palopoli in 1956 while he worked for Merrell Company. It first successfully induced ovulation in women in 1961 and was approved by the Federal and Drug Administration (FDA) in 1967.
Format: Articles
Subject: Technologies
Fortunio Liceti (1577–1657)
Fortunio Liceti studied natural philosophy and medicine in Italy during the first half of the seventeenth century. Liceti wrote greater than seventy works on a wide range of topics, including the human soul, reproduction, and birth defects observed in animals and human infants. In the seventeenth century, people commonly addressed birth defects using superstition and considered them as signs of evil, possibly caused by spiritual or supernatural entities. Liceti described infants with birth defects as prodigies and monsters to be admired and studied rather than feared.
Format: Articles
Subject: People